Join our daily newsletter At The Bell to receive exclusive market insights
The ASX200 has pared early losses trading flattish green leading into close.
Real Estate was the dominant sector dragging the index higher, followed by Discretionary and Utilities. Across the ditch, New Zealand’s Reserve Bank cut the kiwi interest rate down to 3%, causing some contagion upside down under.
But the Materials sector was slaughtered today, down 2.5% in the final hour of trade, followed by Health Care, IT, and Energy.
In the Green
Lynch Group (ASX:LGL) jumped on news its set to be acquired by Hasfarm Bidco, a part of TPG Capital Asia. Under the deal Lynch shareholders will receive $2.25 per share in cash.
Stockland (ASX:SGP) charged higher after stellar FY25 results, including a statutory profit of $826 million, more than doubling the $305 million recorded in FY24.
And, AI play RocketBoots (ASX:ROC) was in the green after inking a trial contract with one of Mexico’s biggest banks. The company’s platform will be used in multiple bank branches with the potential to scale-up.
In the Red
James Hardie (ASX:JHX) bled on release of its Q1 FY26 results and revised full year guidance. The June quarter saw net sales fell 9% year on year to US$900 million, while operating income dropped 41% to US$139 million.
Bourse behemoth CSL (ASX:CSL) retreated for a second day after revelations it will slash around 3,000 jobs, some 15% of its global workforce. The company said numerous pressures, notably Trump’s proposed tariffs, contributed to the move.
And, pharma play Invion (ASX:IVX) was down leading into close despite the U.S. Food and Drug Administration granting Orphan Drug Designation to its lead cancer drug candidate, INV043, for the treatment of anal cancer.
-1200x645-380x200.jpg)
